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1. Introduction 
Osteosarcoma is the most common primary bone tumor. These tumors have long been 
known to be very aggressive in their natural history and therefore for a very long time 
amputation was considered to be the only way to achieve local control of the tumor in the 
limb. Even after an amputation, only 10-20%survived1,2, the rest succumbing to systemic 
disease3,4. 
In the last 30 years a sea of change has occurred in the outlook for these cancers. 
Chemotherapy has allowed better local and systemic control5, 6. Better imaging with CT and 
MRI has allowed the surgeon to accurately define the extent and therefore plan tumor 
resection. Advances in bioengineering have provided exciting options for reconstruction 
and the world has moved from amputation to limb salvage. In osteosarcoma, survival 
improved from dismal 10-20% to 50-70%7, 8. Long term studies showed that limb salvage 
operations, performed with wide margins and chemotherapy did not compromise the 
survival or local control compared to an amputation9-14. 
Cheaper and yet effective chemotherapy protocols and low cost indigenously manufactured 
megaprosthesis have allowed limb salvage surgery to develop even in the poorer countries. 
Good surgical technique has improved functional results and made limb salvage today, the 
standard of care for osteosarcoma. 
2. Evaluation 
The patient is first assessed clinically and a mental impression formed whether the limb is 
salvageable, borderline or non salvageable. All patients undergo an imaging workup for local 
extent and distant spread. This is done prior to a biopsy. An MRI of the local area helps further 
define the extent and relationships to vital structures like the neurovascular bundle. The MRI 
helps us plan the margins of resection. The commonest site of distant metastases is the chest. 
An xray of the chest and where limb salvage is considered a CT scan of the chest (if the x-ray is 
clear) helps to screen for pulmonary metastases. A bone scan is used to screen for skip lesions 
and osseous metastases. A PET-CT scan is now being increasingly used for staging instead of 
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CT chest and bone scan. Presence of distant metastases decreases cure rates but with effective 
treatment when the metastases are resectable, cure rates of 20-40% have been reported.  
3. Biopsy 
Irrespective of how typical the imaging appearance, a histopathological diagnosis is a vital 
step in the diagnostic work up of bone tumors. Fine needle aspiration provides only 
cytologic material and is not the preferred method for diagnosis of primary bone tumors 
like osteosarcoma15. For bone tumors, the cellular architecture as well as the quality of 
matrix has to be studied for a proper diagnosis which FNAC cannot provide. A tissue 
sample may be obtained either by an open incisional biopsy or a closed core biopsy. 
Traditionally an open biopsy has been used. Various complications related to open biopsy 
like incorrect placement of incision, large scale contamination of tissues, infection and 
pathological fracture have often forced an amputation when otherwise a limb salvage was 
feasible. This happens more frequently when the open biopsy procedure is performed by 
individuals not experienced in managing tumors. A badly done biopsy can negatively 
impact overall survival16-21. We therefore recommend that open biopsy should only be 
performed in specialized units by surgeons experienced in managing tumors.  
Percutaneous core biopsy of bone lesions provides early and definitive diagnosis. The 
biopsy site chosen should be such that the tract can be excised en bloc with the tumour. The 
periphery of the tumour is the best site and the pre biopsy MRI may help in localizing the 
most representative area. Necrotic or heavily calcified or ossified areas are avoided. A soft 
tissue mass is adequately representative for a biopsy. Where necessary an imaging C-arm or 
CT guidance is used.  
4. Patient education 
The patient and the patient’s family participate in the decision making process. They are 
counseled in detail especially when limb salvage is considered regarding the costs, change 
in lifestyle and mobility and risks involved. The possibility of an amputation and other 
complications is explained. Amputation as an alternative is also offered in an unbiased 
way and the patient is encouraged to make his own decision. An attempt is made to 
facilitate a meeting between the prospective limb salvage candidate and a patient who has 
already undergone the procedure. Photographs and videos are also shown to the patients 
and their families. 
When the patient and the family are fully informed and participate in the choice of 
treatment, they are much more likely to be satisfied with the ultimate outcome, even if 
complications and problems arise at a later stage. It is important to stress to patient and their 
family that limb salvage may require additional procedures either in near or distant future 
to manage some of the complications. 
5. Indications for limb salvage surgery 
Long term clinical case studies have shown that a limb salvage procedure has the same 
survival as an amputation9-14. Therefore every patient with a malignant tumor of the 
extremity is considered for limb salvage if the tumor can be removed with an adequate 
margin and the resulting limb has satisfactory function. An adequate margin is one that 
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results in an acceptably low rate of local recurrence of the tumor. An adequate margin is 
generally wide in most areas. It may be close in some areas for example in the case of a 
distal femur resection, the popliteal vessels may be on the pseudocapsule but can be easily 
separated and experience has shown an acceptable low rate of local recurrence. After 
salvage the limb should have an acceptable degree of function and cosmetic appearance 
with a minimal amount of pain, and should be capable of withstanding the demands of 
normal daily activities. It must look and function comparable or better than an artificial limb 
after amputation. Balancing these sometimes conflicting requirements is what makes limb 
salvage surgery a complex and difficult, but rewarding process. 
In selected cases, limb salvage can be combined with metastatectomy. For patients with 
uncontrollable disease, limb salvage should be considered if the surgery can be 
accomplished with minimum morbidity and rapid return to function. These patients can 
enjoy relief from pain, improved quality of life, and intact body image that limb salvage can 
offer, even if they may not survive long term. 
6. Barriers to limb salvage 
Barriers to limb salvage include poorly placed biopsy incisions, major vascular involvement, 
encasement of a major motor nerve, pathological fracture of the involved bone, infection and 
inadequate motors after resection. These adverse factors are barriers but not absolute 
contraindications. For example in pathological fractures, the fracture often heals with 
chemotherapy and the specimen can be removed with adequate margins. Ability to transfer 
motors, graft nerves and vessels and provide skin cover with microsurgical methods have 
allowed successful limb salvage despite many barriers. If the patient has limited financial 
resources, it is better to spend the money on chemotherapy and do an amputation rather 
than doing limb salvage and not giving chemotherapy. 
7. Surgical resections and reconstructions 
For successful local tumor control it is essential to achieve a complete resection of the tumor 
with an adequate margin (Fig 1). As stated earlier, an adequate margin in any particular case 
remains controversial25. For high grade sarcomas, a wide margin is considered adequate and 
will achieve successful control of the primary tumor approximately 95% of the time, 
whereas marginal or intralesional margins are associated with higher rate of local recurrence 
and poor outcomes26. For bone 3cm away from the extent on T1-MRI image is adequate27-32. 
The marrow is always sent from the cut end for frozen section evaluation for tumour. If 
positive the resection is revised. For the soft tissue 1-2cm margin is preferred wherever 
possible. In practice, the line between a wide and a marginal margin is sometimes difficult 
to define as the surgeon strives to control the tumor while still leaving the patient with a 
useful limb. However, when in doubt, the surgeon errs on the side of excess tissue removal. 
The adequacy of the margin can be judged by bivalving the specimen. If there is any doubt 
about margins, a frozen section can be done and a decision for an amputation can be made 
on table. This is the reason that any patient undergoing a limb salvage procedure is 
forewarned about this possibility and a consent for amputation always obtained. 
After completion of the tumor resection, the surgeon must reconstruct the resulting surgical 
defect. The surgeon must eliminate potential dead space and transfer tissues if necessary to 
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allow an effective closure. Occasionally, the reconstruction or substitution of a segment of 
artery or nerve may be required.  
Most osteosarcomas occur in the metaphyseal portion of the bone, so that the typical 
resection involves the whole proximal or distal part of the bone. If the joint is not 
contaminated by the tumor, an intraarticular resection is performed through the joint. If the 
joint is contaminated, then an extraarticular resection is required, taking the entire joint and 
joint capsule, and cutting through the uninvolved bone on the other side of the joint to 
achieve a wide margin. The gap remaining needs reconstruction either with metal or with 
bone or a composite of the two. For tumors that involve the diaphyseal portion of a bone, an 
intercalary resection and reconstruction can be performed that saves the joints at either end. 
It is now possible to save the joint even if only 1.5-2cms of condyle thickness remain27. For 
low grade osteosarcoma, a hemicortical excision which removes only a part of the bone 
circumference is effective in disease control. The reconstruction done often depends on the 
kind of defect (fig 2). 
 
Fig. 1. Margins considered adequate for high grade osteosarcoma excision.The figure shows 
a resection specimen of the distal femur osteosarcoma. It is covered by an uninvolved 
muscle layer. The biopsy track has been completely excised enbloc with skin. There is 3cm 
margin from marrow extent of tumor at proximal end and the joint cartilage as margin for 
the distal end. 
7.1 Hemicortical defects 
These result generally from partial circumferential excision of benign or low grade tumors 
like a parosteal osteosarcoma. Reconstruction of these defects can be done by a shaped 
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allograft or by fibula or iliac crest strut autograft.28 Because of the large contact area and 
vascularity of the bed, usual complications associated with allografts like infection, non-
union and fracture are rare. We reported our results in ten cases with complete 
incorporation of the graft in all the cases and no local recurrence.28 
 
Fig. 2. The various kinds of bone defects resulting from an excision of an osteosarcoma. 
Hemicortical excision can be done for a low grade osteosarcoma like parosteal 
osteosarcoma. For all others, a full segment resection is advised. 
7.2 Full segment defects 
These are a result of complete circumferential excision of bone segments. These can be 
intercalary or joint involving (Fig 2). Since most tumors occur around the metaphysis, joint 
involving defects are more common. 
7.2.1 Joint involving defects 
7.2.1.1 Megaprosthesis 
Megaprosthesis is a large metallic joint designed to replace the excised length of bone and 
the adjacent joint. These are fully constrained hinge joints. They provide an immediate 
return to function and are not affected by ongoing adjuvant treatment like chemotherapy 
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and radiotherapy. They thus form the mainstay in limb salvage surgery for reconstruction 
after tumor resection. 
Advances in metallurgy and fabrication have tremendously improved these joints. Joint 
breakage is now rare and aseptic loosening rates are also very low with the use of rotating 
hinges and with extracortical bridging between the bone and implant collar.29 Infection 
and local recurrence are the commonest cause of prosthesis failure and happen in around 
15% of cases. 
A customised joint has to be ordered as per individual patient’s dimensions. It takes 4-6 
weeks for fabrication. In contrast modular systems (Fig 3) allow for immediate availability. 
They also allow intraoperative flexibility. The drawback is that they are expensive and a 
large inventory of the components has to be kept. A customized prosthesis can be improved 
with every joint but this is not possible for a modular system. Currently modular systems 
are used for most adults and children near skeletal maturity as adequate modularity ensures 
a good fit into the defect for almost all patients. In children or in places where anatomy is 
distorted, customized implants are used to adjust for smaller or abnormal bone size and to 
allow expansion. 
 
Fig. 3. Figure showing a modular megaprosthetic system for distal femur or proximal tibia 
resection (RESTOR, Adler Mediquip Pvt Ltd, India). Note that numerous components 
linked to assemble the complete prosthesis. The modularity allows the implant to be 
matched to the defect as well as to the bone in which it is to be implanted. 
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Special attention is paid during closure to ensure that the prosthesis is fully covered by a 
healthy soft tissue envelope. Wherever possible, as in proximal tibia, tendons are reattached 
to the construct. In the proximal femur, wherever possible, reattachment of the abductors 
reduces the limp. In the shoulder, the rotator cuff is lost and the proximal humerus implant 
works as a mere spacer to allow function of the elbow and hand. Wherever the deltoid and 
axillary nerve can be preserved, a reverse shoulder implant can be used.30 This allows active 
flexion and abduction which was not possible with the conventional implant. Scapular 
endoprosthesis after a scapulectomy may provide better function than simple humeral 
suspension of the latissimus dorsi, trapezius, deltoid and rhomboids can be preserved with 
better abduction and flexion.31 
It is now possible to reconstruct the entire humerus or femur (fig 4)with prosthesis. Though 
the surgery involves a massive exposure and long duration, the functional results have been 
superior to that after an amputation and external prosthesis.  
 
Fig. 4. A total Femoral endoprosthetic replacement 
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Fig. 5. An expandable distal femur megaprosthesis. This is a minimally invasive expandable 
system. The screwdriver drives a wormgear mechanism to drive out a telescoping cylinder 
resulting in lengthening. 
Regardless of the method of fixation to the host bone, the prosthesis may loosen over time. 
Mechanical wear of the polyethylene bearing surfaces can lead to failure of the 
reconstruction. Rebushing is required more commonly in the fixed hinge implant and 
generally after five years.29, 32 Using an hydroxyapatite coated or porous coated collar to 
allow extracortical bone bridging between host bone and implant has reduced the rates of 
aseptic loosening to almost zero.29 Breakages are now rare with the use of stronger metals 
and superalloys like titanium and Chrome-cobalt. When these implants fail, revision 
procedures though complex have generally been successful after implantation of a new 
prosthesis.33 
7.2.1.2 Expandable prosthesis 
Managing limb lengths is a challenge in young children treated with limb saving surgery. 
While they are cured of cancer, the operated leg becomes shorter as the normal leg 
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continues to grow while the operated leg does not. This required the child to use shoes 
with a thick heel to compensate for limb length discrepancy but also resulted in limp and 
poor function. To overcome these problems, a special prosthesis was designed which 
could be lengthened periodically (expandable prosthesis). The prosthesis had a worm-
gear mechanism which allowed a telescoping cylinder to increase the length when a screw 
was turned (Fig 5). This was done surgically by a small operation in which a small cut 
was made and a screw driver used on the prosthesis to turn a screw which allowed a tube 
to telescope out. This had to be done repeatedly as the child grew to keep pace with the 
growth of the normal side. Though surgery was involved, the fact was that now length 
could be maintained in these children.  
Even with all these advances, it means that the child has to undergo multiple surgical 
procedures for lengthening. It means admission to hospital, anaesthesia and surgery, all of 
this adding to the costs of treatment. Also, since we want to minimize the number of 
operations required, we lengthen more at each operation. We try to lengthen 1cm or more 
depending on the child and the need. Every surgery results in some stiffness, pain and time 
to rehabilitate to come to normal as this much growth is not easily adjusted to by the body. 
Each surgery also increases the risk of infection which is estimated to be about 8% in the 
current era.34  
In order to solve some of the problems above, prostheses have been developed which can be 
expanded remotely without the need of any surgery. We have used the implant made by 
stanmore implants worldwide, U.K. The prosthesis has a very sophisticated mechanism 
sealed inside it which allows lengthening to happen with the help of an electromagnetic 
field.35 A rare earth magnet is placed along with a motor and a gear system inside the 
prosthesis. A coil from outside around the implant can now generate an electromagnetic 
field to turn the motor. Through a system of miniature gears, the movement of the motor 
can allow the expansion of the implant by moving the telescoping tube out just like it was 
done with a screw driver. The biggest advantage is that now surgery is not required for 
lengthening. Small amounts of lengthening are done more like normal growth. There is no 
pain or stiffness, no hospitalization and no risk of infection. In the long run this turns out to 
be cheaper than the minimally invasive implant.  
7.2.1.3 Osteoarticular allografts 
Allografts offer the surgeon additional reconstructive options in bridging large bone defects 
after tumor excision. Osteoarticular allografts have shown a success rate of 70% at long term 
follow-up.42. Allografts have the advantage of providing biological bed for soft tissue 
anchorage. The attachment of muscle insertions is more successful in allografts than in 
prostheses, yielding better function in some sites. Initial enthusiasm for allografts has been 
tempered by a variety of problems as experience has accumulated. While it was initially 
hoped that massive allografts would become fully incorporated into the host, retrieval data 
show that only a small percentage of the allograft actually becomes revascularized, while 
the rest remains necrotic 43, 44. Rather than a biologic replacement for the excised bone 
segment, the allograft functions as a biologic spacer. Massive allografts are susceptible to 
infection (5-15%), fracture (15-20%), Non-union (15-20%) and osteoarthritis from collapse of 
the articular surface (with osteoarticular graft) 45-49. Chemotherapy and radiotherapy can 
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adversely affect the union rates48-52. An additional concern is the potential for the 
transmission of bacterial or viral disease.  
7.2.1.4 Alloprosthetic composite and others 
Sometimes a composite of an allograft and an endoprosthesis is used for certain limb-
salvage reconstructions. An appropriate allograft is selected and implanted to replace the 
segment of bone resected. The articular surfaces of the graft are excised and replaced using 
conventional techniques of total joint arthroplasty. The allograft provides a source of bone 
stock and a site for tendon insertions, while the prosthesis provides a reliable and stable 
articulation and some support for the allograft. The surgeon can customize the implant for 
any particular need. An allo-prosthesis construct has a lower fracture rate than allograft 
alone49 and is not susceptible to osteoarthritis. 
7.2.1.5 Resection arthrodesis 
Arthrodesis for the knee, though disabling can provide a practical low cost option for 
reconstruction after bone tumor resection especially if patient is likely to engage in heavy 
manual labour. Even in a developing country it causes difficulty with squatting, traveling in 
bus, etc. It is therefore not easily accepted and done only occasionally by us. The principles 
of surgery involve bone grafts coupled with internal fixation, very similar to those of 
intercalary resections. Allografts alone, unlike in intercalary resections have shown a high 
failure rate due to infection, fracture and non-union.53-54  Autografts vascularised or non-
vascularised are used along with fixation which is either a locked long nail, or a long plate 
or sometimes an external fixator.55  Distraction osteogenesis has been another option used 
particularly in benign tumors. An intramedullary nail, double osteotomy, fewer rings and 
early fixator removal have reduced the complication rates.55  We have preferred to use a 
double barrel live fibula or an allograft combined with a live fibula and neutralized with a 
long plate.(fig 6) 
The defect can be bridged by using autograft or an allograft or a combination. A 
vascularised live fibula with allograft supplementation is a good alternative and our method 
of choice. A non vascularised graft always has the risk of fracture. Fixation is either with a 
plate spanning the defect or with a long customized nail. These patient have to be 
immobilized for a long time till union. Besides, radiotherapy and chemotherapy can 
interfere with union. An intercalary long segment allograft can be used with implant 
fixation but has a high rate of complications45. Even with an autograft, non union and 
fracture rates are high and it is almost a year before arthrodesis is sound. Till this time the 
patient has to be protected and load bearing restricted. 
Functionally, the gait of these patients with knee arthrodesis is a little awkward due to the 
stiff knee and sitting is difficult. However these patients are not afraid of loading their limb 
and can engage in strenuous activities56.  
Very few of our patients opted for an arthrodesis. The ones that did, did it for reasons of 
cost. The low cost of the megaprosthesis made it easier for patients to opt for a mobile 
reconstruction. Occasionally a nail and cement arthrodesis is used in cases where long term 
survival is unlikely (palliative limb salvage). A long K nail is used with cement to bridge the 
defect. The cement provides rotational stability. In these cases patient can be ambulant 
immediately.  
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Fig. 6. An allograft with a pedicled (vascularised) fibula for a resection arthrodesis of the 
knee. The allograft is hemicylindrical to avoid any compression of the pedicle or skin 
attached to the fibula. The xray shows the union at junctions which happened uneventfully 
in less than 6 months. 
7.2.1.6 Rotationplasty 
Rotationplasty is a procedure which allows the ankle to substitute as the knee after 1800 
rotation of the limb. The original idea was conceived by Borggreve in 1927 to treat a 
shortened lower limb with stiff knee after tuberculosis and popularized by Van Ness for 
management of proximal focal femoral deficiency57. Salzer in 1974 first used it for malignant 
tumors around the knee58. It is essentially an intercalary limb resection preserving the 
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continuity of the neurovascular bundle. The limb continuity is established by fusing the 
Tibia with the proximal femoral remnant after 1800 external limb rotation. This allows the 
ankle joint to come to the level of the knee and its axis of motion corresponding with the 
original knee. A special external prosthesis then is fitted allowing the patient to ambulate. 
Ankle movements now simulate knee movements (Fig 7). This reconstruction therefore 
functions like a below-knee amputation. A big advantage is that the sole being the normal 
weight bearing area, there is no phantom pain. The stump can be left longer in children to 
account for subsequent shortening with growth. These patients are able to walk normally, 
run, participate in leisure outdoor sporting activities, ride a bicycle and drive a car etc.  
 
Fig. 7. Rotationplasty. A: the rhomboid incision taken. B &C : The Anteroposterior and 
lateral xrays of a femoral osteosarcoma after induction chemotherapy. D: postoperative xray 
showing the osteosynthesis between the proximal femur and proximal tibia using a plate. E: 
The clinical appearance of rotationplasty 
Though very well described in literature with functional results comparable to an 
endoprosthetic reconstruction59-62, the limb disfigurement produced has been a psychological 
barrier to widespread acceptance especially in the developed world. Most series for functional 
evaluation have shown superior functional results compared to megaprostheses, but small 
numbers in rotationplasty group have made statistical evaluation difficult.62-63 Patients with 
rotationplasty are reported to have less pain and are more likely to participate in sports as 
compared to megaprostheses.61 Akahane et al64 in a small group of 17 patients reported better 
function and quality of life results with a rotationplasty than with an endoprosthesis. 
Rotationplasty is a low cost alternative to prosthesis in a developing country like India.65 The 
surgical procedure is straightforward, the external orthoses cheap and easily available and 
with no revisions necessary coupled with the ability to squat and load the limb make it an 
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easily accepted alternative over amputation for the economically backward. In children one 
can adjust the stump length for growth and avoid all the problems and costs associated with 
expandable prosthesis and expansions. It also works as an excellent salvage option for a failed 
megaprosthesis, especially after infection.66  Another advantage is that with large tumors and 
extensive quadriceps involvement (common in a developing country like India), it can still 
provide functionally good outcome. An osteotomy of the femur early in the procedure allows 
limb rotation and makes dissection of the neuro-vascular bundle easier.66 A specially designed 
jig helps to cut the bone perfectly perpendicular to the long axis and makes osteosynthesis 
between tibia and femur easier.65-66. Rotationplasty can be performed in even in smaller 
hospital setups without need for complex instrumentation. Long term results have not shown 
any arthroses in the ankle joint proving excellent adaptation.67   
We have found excellent functional scores and patient satisfaction with this method. This 
has to be compared with an high above knee amputation or hip disarticulation where even 
with an artificial limb the function is inferior. Walking speeds,  gait,  oxygen consumption 
and  general  efficiency  were better or comparable with other procedures like arthrodesis, 
endoprosthesis & amputation68-70. Though cosmetically unappealing, functional benefits 
overshadow the appearance. Prior to surgery the patient is shown photographs and videos 
and wherever possible meets another similar patient. The mental preparation goes a long 
way in ultimate acceptance by the patient. 
7.3 Intercalary defects 
Intercalary defects are broadly classified as diaphyseal, metaphyseo-diaphyseal, or 
epiphyseodiaphyseal (fig 8).68 
 
Fig. 8. Various types of intercalary defects depending on the level of distal and proximal cut 
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7.3.1 Autografts and allografts 
Although numerous problems continue to limit the success of allograft reconstructions, they 
remain a viable choice for selected uses, especially in the upper extremity, for intercalary 
resections, and for patients who will not need chemotherapy. Intercalary allografts have 
shown higher success than the osteoarticular ones46. Reconstruction of epiphyseo-
diaphyseal defects with allografts is challenging. Despite the large cancellous bony contact 
surface, lack of rigid fixation at the epiphyseal end delayed the average time to union to 18 
months compared to 13 months at metaphyseal end.68 Vascularised fibula (VF) is a good 
alternative for intercalary defects especially for longer gaps.69-70 VF showed 93% union rate 
with only 15% delayed union  as compared to allografts which have had 68-90% union rates 
with 51-57% delayed union rates.69 Most of VF patients could return to athletic activity. 
Donor site morbidity was not a serious problem with most complications resolving with 
conservative treatment.  
 
 
Fig. 9. A: Osteosarcoma of the femur treated by an intercalary resection. The surgeon 
reconstructed the defect with an interlocking nail only which broke in 2 years. This was 
replaced by an Allograft with a vascularised fibula placed in the intramedullary canal (B). C 
& D show the follow up xray at one year showingthe excellent incorporation of graft and 
fibular hypertrophy 
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Non vascularised fibular autograft can be a simple low cost and yet effective alternative to 
Allograft or VF. Krieg et al71 reported from their experience of 31 cases using a non  
vascularised fibula a primary union rate of 89% in a median time of 24 weeks. 15% had a 
fatigue fracture with no fractures where a double or triple strut was used. Hypertrophy of 
the graft was similar to that in VF.  
The results of allograft can be improved by combining them with a vascularised fibula 
either placed in the medullary canal of the allograft or as an onlay by providing 
vascularity in the centre of the allograft.72-73 The healing of the junctions is quick and 
reliable and the fibula hypertrophies over a period of time. The allograft provides the 
initial strength and the vascularised autograft provides speed of union. Our experience 
with radiated allograft alone has been rather disappointing with only about 40% grafts 
incorporating. Radiation and chemotherapy have probably resulted in poorer 
incorporation. A single fibula especially in defects over 20cm was prone to fracture. We 
therefore recommend an allograft combined with a live fibula rather than an allograft 
alone for long full segment defects. The faster incorporation results in fewer failures and 
earlier return to full function. For smaller defects with strong and rigid fixation, a VF 
alone may be adequate.  
7.3.2 Reimplantation of tumor bearing bone 
Reimplanting the tumor bearing bone after some form of treatment (autoclaving, 
pasteurization, freezing with liquid nitrogen, or extracorporeal radiation) to kill the tumor 
cells is another exciting low cost option. Though dead like an allograft, it is perfectly 
matched to the defect. Autoclaved bone has provided fairly good results as reported from 
12 cases from Pakistan with only one non-union and no fractures with an average MSTS 
score of 70% at a mean follow-up of 49 months.74 Yamamoto et al75 histologically 
examined a specimen of autoclaved and reimplanted bone in femur retrieved after 24 
months and found most of the graft not incorporated. New bone formation was thin and 
superficial over the graft and bone scan exaggerated the bone formation. This does not 
seem to match the clinical experience cited above. In future it may be possible to improve 
the osteoinductivity of autoclaved bone by coating with rhBMP-2.76 A combination of 
dehydration and thermal denaturing can prevent loss of strength and improve clinical 
performance.77 
High temperatures associated with autoclaving are known to damage the collagen 
matrix leading to loss of strength as well as BMP and osteoinductivity. Pasteurisation 
involves heating the bone to 60 deg C for 30 min in a water bath and is an effective way 
of killing all tumor without affecting strength and osteoinductivity. Clinical results with 
pasteurized graft have shown results at least comparable to allografts.78-79 Freezing in 
liquid nitrogen is another way of killing the tumor and yet being able to reimplant the 
bone. Tsuchiya et al80 reported bony union at a mean of 6.7 months after the operation in 
26/28 patients. There were three deep infections, two fractures, and two local 
recurrences. 
Extracorporeal irradiation (FIG 10) with doses of 5000rad (equivalent to 25kgy of 
conventional radiation) is also effective in killing all tumor.81 The rate of non union (7%) is 
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significantly lower with ECRT as compared to allografts (43%).82  The fracture rates were 
similar and there were no infections. Histological evaluation of specimens from failed ECRT 




Fig. 10. A: Preoperative xrays of an osteosarcoma of the femur treated with extracorporeal 
irradiation and reimplantation(ECRT). B: schematic view showing the custom plates made 
to fix the construct. C: The postoperative xray showing the radiated autograft construct. 
Note the screws close to the distal physis. D: followup xray showing incorporation of the 
graft and growth from the distal femoral physis. 
As in an allograft, a live fibula improves the results with pasteurized as well as radiation 
treated bone.71, 73, 84 
7.3.3 Prosthesis 
Prosthesis can be used to reconstruct non-joint defects. These can be used as physis 
sparing or joint saving implants.27 Endoprosthetic reconstruction of a diaphyseal defect 
avoids the donor site morbidity of autograft and the fracture and non-union risk of 
allograft especially for patients on chemotherapy. It also shortens surgical time 
significantly as compared to a VF. Clinical results have been at least as good as 
allografts.85, 86 The higher rate of loosening in the upper limb may be due to rotational 
stresses. The aseptic loosening may be reduced with hydroxyapatite (HA) or porous 
titanium bead coating.29  Customised HA coated implants have been used for epiphyseo-
diaphyseal defects. (fig 5) Early stability is obtained by extracortical plate fixation. No 
loosening or fractures were reported from 8 cases studied with a short follow up of 3 
years.87 This implant can be expandable where the physis is resected to maintain limb 
length with growth.(fig 11) The early results are promising and this could become the 
method of choice for intercalary reconstruction. 
www.intechopen.com
 Limb Salvage for Osteosarcoma: Current Status with a Review of Literature 125 
 
Fig. 11. A: Preoperative xray of a distal femur osteosarcoma. B: The MRI shows the extent 
just proximal to the distal femoral physis. Note the skip lesion proximally. C: The defect was 
constructed with a custom prosthesis designed to fit into the small distal and proximal 
fragment. The distal fixation is with an hydroxyapatite coated surface and small 
extracortical plates. The proximal fixation is with a curved short intramedullary stem. This 
prosthesis could be lengthened with a noninvasive expansion mechanism (STANMORE 
implants, UK) 
8. Pelvis 
Any tumor in the pelvis is a challenge to an orthopaedic oncologist for resection and 
osteosarcoma being a high grade malignant tumor is even more challenging. Tumors are 
often large at presentation and do not always respond well to the preoperative 
chemotherapy. Osteosarcomas of the pelvis are rare accounting for 7-9% of all 
osteosarcomas.88 Prognosis has been reported to be dismal with 18% 5 year survival88,89,90 . 
Recent report indicates a 50% 5 year survival.91 Since osteosarcoma does not respond well to 
radiation, surgical resection with a tumor free margin is the only reliable method for cure. 
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The surgery is extensive and has the potential for many complications. An external 
hemipelvectomy has therefore been the standard of care in the past. Though it causes major 
disfigurement and extensive functional handicap, it was the safest way of getting a chance 
of cure in a pelvic osteosarcoma. With improvement in imaging as well as surgical 
technique and technology, limb saving resections have now become feasible and are the 
standard of care. 
Pelvic resections for tumors are amongst the most challenging of operations for any 
surgeon. A detailed knowledge of anatomy and preparedness and ability to deal with large 
blood losses is a prerequisite. Pelvic resections are any one or the combination of the 
following four types. Type I (Iliac), Type II (periacetabular), Type3 (anterior arch) and type 
IV (sacrum). Classically, internal hemipelvectomy means resection of the entire hemipelvis 
from the SI joint to the pubic symphysis. Today, the term has come to include resections of 
the pelvis which include the acetabulum with varying portions of the Ilium & the anterior 
arch. Resections involving the acetabulum leave behind significantly more instability than 
the other types of partial pelvic resections.  
Pelvic resections are extensive operations associated with the risks of major blood loss as 
well as wound problems from the extensive exposure and long surgical time. Resection 
without any reconstruction was done in the past to minimize these complications. With 
improvement in technique and results, reconstruction using arthodesis (iliofemoral and 
ischiofemoral fusion)(fig 12), surgical pseudarthrosis (mesh reconstruction), pelvic 
allografts, custom-made endoprostheses, the saddle prosthesis and reimplantation of the 
excised hemipelvis after sterilisation by radiation have been used with better cosmetic and 
functional results.92  
It is logical to use these extensive surgical procedures only in those with a chance of cure. 
To minimize the incidence of local recurrence, only those patients should be selected 
where the extent of the tumor (judged by a preoperative workup) is such that it  is 
possible  to provide adequate margins for local control by surgery.; ie, tumors involving 
the innominate bone without extension into soft tissue or with minimal or moderate 
extension into soft tissue such that would permit an en bloc resection through clean 
planes and allow preservation of the major nerves and vessels for the ipsilateral 
extremity. Also, the general physical condition and life expectancy  of the patient should 
justify the procedure because of the prolonged rehabilitation period (9-15mo). 
Involvement by the tumor of one of the major nerves, ie, sciatic or femoral, requiring its 
sacrifice, should revise the operative plan to that of a standard hemipelvectomy. Of 
course, such an eventuality should be explained beforehand to the patient, and the 
appropriate consent obtained. 
Tumors located near the sacroiliac joints or pubic symphysis present a special problem in 
that positive margins of resection may occur unless the procedure is extended to the 
sacral ala or the contralateral side of the symphysis, respectively. Also, lesions medial to 
the pelvic bones may be adjacent to the neurovascular bundle and result in positive 
margins of excision. Induction chemotherapy may be useful to shrink these tumors prior 
to their surgical removal and thereby facilitate removal with more adequate resection 
margins.  
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Fig. 12. An Iliofemoral fusion held with a distal femur condyle buttress plate. This is 
contoured to match the bone contour. 
The incisions needed for each case may be different depending on the resection and 
reconstruction planned. A wrongly done biopsy is very likely to compromise the chance of 
limb salvage. It is therefore recommended that biopsy be best done by the surgeon who will 
be performing the final procedure. 
In acetabulum involving resection without reconstruction, a 2-3” shortening of the 
ipsilateral extremity occurs. The patient has normal function at the ankle and knee joints, 
but no function at the hip area. As fibrosis occurs, these patients can walk in 6-9 months 
with help of some support like a crutch or walking stick. The  functional  results could be 
improved  by  stabilising  the pelvis by reconstructing. Hip transposition (mesh 
pseudoarthrosis) has given acceptable results with lower complication rates than other 
methods like prosthesis and allografts.93 Type II resections(periacetabular) have a better 
outcome with allograft and prosthesis composite as compared to more massive complete 
hemipelvic resections.94 Saddle prosthesis provides better function than a hemipelvectomy 
but has a considerable complication rate.95, 96 Infection (37%), dislocation (22%), fractures 
(22%), and heterotopic ossification (37%) were the commonest reported complications.97 
Vertical migration has been noted in some cases. Pelvic allografts have been reported to give  
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Fig. 13. Reconstruction after an extraarticular resection of the proximal femur. The 
acetabulum is reconstructed with a custom acetabular prosthesis and femur with a modular 
proximal femoral megaprosthesis (ISIQU Orthopaedics, Capetown, South Africa). The 
acetabular prosthesis anchors into the posterior ilium, pubis and ischium with small stems 
which are cemented. 
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Fig. 14. Acetabulum reconstructed with a modular coned hemipelvic implant (Stanmore 
implants worldwide, UK). The stem is uncemented and fits into the thick posterior ilium 
remnant. Additional screws pass into the ilium and the defect is bridged with cement. An 
uncemented standard femoral component used in hip replacement surgery is placed in the 
proximal femur and mated to the cup with a constrained liner. 
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good functional results though the complication rate has been high.97 Nonunion, infection 
and local recurrence were the commonest complications.97 Custom or modular acetabular 
prosthesis have also been used with satisfactory functional results in some reports98,99,100 and 
poor results in others.101 Similarly custom or modular hemipelvic prosthesis have been 
reported with poor101 or satisfactory results.102 
Complication  rates in various series varies from  42-65%. Infection and local recurrence are 
the biggest complications. Injury to NV bundle,  ureter,  bladder  & rectum are 
the  other  complications  described. Injury  to the sciatic nerve would severely compromise 
the  functional result. Sciatic and femoral nerve palsies have been reported frequently after 
pelvic resections and reconstructions.93, 95, 97 
We have preferred to use either modular coned hemipelvis (fig 14) from Stanmore implants 
or extracorporeal irradiation and reimplantation with or without a hip prosthesis. Wherever 
enough bone stock is present, an arthrodesis like iliofemoral or ischiofemoral fusion is 
used.(fig 12) 
9. Conclusions 
The first decade of the new millennium has been globally recognized by the orthopaedic 
fraternity as the decade of improvements in the treatment of bone and joint disorders. An 
ideal situation in the management of bone tumors is when the disease can be successfully 
removed without an amputation and the resulting loss of bone and muscle compensated by 
a method which retains near normal limb function. Patient survivals have dramatically 
improved following the availability of newer chemotherapy drugs and this has accentuated 
the need for durable methods of reconstruction of  large musculoskeletal defects. 
Orthopaedic surgeons have  risen to the challenge and it is now  possible to offer limb 
salvage to a large majority of patients with bone tumors. Ever increasing advances in 
technology and biomaterials combined with a better understanding of biomechanics will 
further help in increasing the durability of and refining limb salvage procedures. 
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